Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Bootz

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Plos One|September 20, 2014
Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytesSven Brandau, Mark Jakob, Kirsten Bruderek, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 7, 2008
Analysis of manual segmentation in paranasal CT imagesKathrin Tingelhoff, Klaus W G Eichhorn, Ingo Wagner, et al.
Epigenetics|April 14, 2020
The landscape of <i>CD28, CD80, CD86, CTLA4</i>, and <i>ICOS</i> DNA methylation in head and neck squamous cell carcinomasLuka de Vos, Ingela Grünwald, Emma Grace Bawden, et al.
Oncotarget|February 9, 2018
<i>PD-L1</i> (<i>CD274</i>) and <i>PD-L2</i> (<i>PDCD1LG2</i>) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomasAlina Franzen, Timo J Vogt, Tim Müller, et al.
Clinical Epigenetics|February 9, 2017
<i>PITX3</i> DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinomaVerena Sailer, Emily Eva Holmes, Heidrun Gevensleben, et al.
Oncotarget|May 11, 2017
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patientsDiane Goltz, Heidrun Gevensleben, Joern Dietrich, et al.
British Journal of Cancer|April 4, 2018
Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort studyJulia Bergheim, Alexander Semaan, Heidrun Gevensleben, et al.
Clinical Chemistry|January 11, 2019
Cell-Free <i>SHOX2</i> DNA Methylation in Blood as a Molecular Staging Parameter for Risk Stratification in Renal Cell Carcinoma Patients: A Prospective Observational Cohort StudyMaria Jung, Jörg Ellinger, Heidrun Gevensleben, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 6, 2013
Brief S2k guidelines--Cutaneous squamous cell carcinomaHelmut Breuninger, Thomas Eigentler, Friedrich Bootz, et al.
The Journal of Molecular Diagnostics : JMD|May 4, 2020
Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective StudyLuka de Vos, Maria Jung, Ruth-Miriam Koerber, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Plos One|September 20, 2014
Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytesSven Brandau, Mark Jakob, Kirsten Bruderek, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 7, 2008
Analysis of manual segmentation in paranasal CT imagesKathrin Tingelhoff, Klaus W G Eichhorn, Ingo Wagner, et al.
Epigenetics|April 14, 2020
The landscape of <i>CD28, CD80, CD86, CTLA4</i>, and <i>ICOS</i> DNA methylation in head and neck squamous cell carcinomasLuka de Vos, Ingela Grünwald, Emma Grace Bawden, et al.
Oncotarget|February 9, 2018
<i>PD-L1</i> (<i>CD274</i>) and <i>PD-L2</i> (<i>PDCD1LG2</i>) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomasAlina Franzen, Timo J Vogt, Tim Müller, et al.
Clinical Epigenetics|February 9, 2017
<i>PITX3</i> DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinomaVerena Sailer, Emily Eva Holmes, Heidrun Gevensleben, et al.
Oncotarget|May 11, 2017
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patientsDiane Goltz, Heidrun Gevensleben, Joern Dietrich, et al.
British Journal of Cancer|April 4, 2018
Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort studyJulia Bergheim, Alexander Semaan, Heidrun Gevensleben, et al.
Clinical Chemistry|January 11, 2019
Cell-Free <i>SHOX2</i> DNA Methylation in Blood as a Molecular Staging Parameter for Risk Stratification in Renal Cell Carcinoma Patients: A Prospective Observational Cohort StudyMaria Jung, Jörg Ellinger, Heidrun Gevensleben, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 6, 2013
Brief S2k guidelines--Cutaneous squamous cell carcinomaHelmut Breuninger, Thomas Eigentler, Friedrich Bootz, et al.
The Journal of Molecular Diagnostics : JMD|May 4, 2020
Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective StudyLuka de Vos, Maria Jung, Ruth-Miriam Koerber, et al.
Pageof 10